TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial? January 5, 1996
TCL Archive In Brief: Sartorelli AACI President, McInTyre President Elect; Moertel to Receive ACCC Clinical Award July 10, 1987
